Shuenn-Chen Yang

1.8k total citations
22 papers, 1.5k citations indexed

About

Shuenn-Chen Yang is a scholar working on Molecular Biology, Cell Biology and Cancer Research. According to data from OpenAlex, Shuenn-Chen Yang has authored 22 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cell Biology and 5 papers in Cancer Research. Recurrent topics in Shuenn-Chen Yang's work include Epigenetics and DNA Methylation (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Axon Guidance and Neuronal Signaling (3 papers). Shuenn-Chen Yang is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Axon Guidance and Neuronal Signaling (3 papers). Shuenn-Chen Yang collaborates with scholars based in Taiwan, United States and United Kingdom. Shuenn-Chen Yang's co-authors include Pan‐Chyr Yang, Tse‐Ming Hong, Reen Wu, Yu‐Chiau Shyu, Yi-Wen Chu, Cheng‐Wen Wu, Mary J.C. Hendrix, Jin‐Yuan Shih, Yi-Ying Wu and Szu‐Hua Pan and has published in prestigious journals such as Nature Communications, Biomaterials and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Shuenn-Chen Yang

22 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuenn-Chen Yang Taiwan	18	994	474	375	207	183	22	1.5k
Deepa Sampath United States	26	1.5k 1.5×	608 1.3×	452 1.2×	84 0.4×	141 0.8×	68	2.2k
Smitha Pillai United States	22	1.2k 1.2×	469 1.0×	413 1.1×	187 0.9×	111 0.6×	34	1.8k
Qingkai Yang China	21	1.3k 1.3×	310 0.7×	227 0.6×	126 0.6×	232 1.3×	37	1.7k
Xingcong Ren United States	29	1.5k 1.5×	399 0.8×	700 1.9×	231 1.1×	220 1.2×	57	2.6k
Joseph Negri United States	21	933 0.9×	613 1.3×	219 0.6×	108 0.5×	164 0.9×	47	1.6k
Malin Wickström Sweden	27	1.3k 1.3×	650 1.4×	420 1.1×	125 0.6×	142 0.8×	63	2.2k
John L. Darling United Kingdom	24	989 1.0×	506 1.1×	379 1.0×	224 1.1×	197 1.1×	66	2.0k
Rosaria Gangemi Italy	25	1.1k 1.1×	760 1.6×	391 1.0×	164 0.8×	156 0.9×	52	2.2k
Elizabeth A. Kosmacek United States	18	530 0.5×	246 0.5×	169 0.5×	113 0.5×	176 1.0×	45	1.0k
Lydia Puricelli Argentina	26	901 0.9×	551 1.2×	489 1.3×	138 0.7×	183 1.0×	68	1.8k

Countries citing papers authored by Shuenn-Chen Yang

Since Specialization

Citations

This map shows the geographic impact of Shuenn-Chen Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuenn-Chen Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuenn-Chen Yang more than expected).

Fields of papers citing papers by Shuenn-Chen Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuenn-Chen Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuenn-Chen Yang. The network helps show where Shuenn-Chen Yang may publish in the future.

Co-authorship network of co-authors of Shuenn-Chen Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shuenn-Chen Yang. A scholar is included among the top collaborators of Shuenn-Chen Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuenn-Chen Yang. Shuenn-Chen Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Kuo‐Yen, Shuenn-Chen Yang, Sean M. Wu, et al.. (2020). Monocarboxylate Transporter 4 Is a Therapeutic Target in Non-small Cell Lung Cancer with Aerobic Glycolysis Preference. Molecular Therapy — Oncolytics. 18. 189–201. 27 indexed citations

Wu, Yi-Ying, Kuo‐Yen Huang, Shuenn-Chen Yang, et al.. (2019). The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens. Journal of Experimental & Clinical Cancer Research. 38(1). 282–282. 37 indexed citations

Hong, Tse‐Ming, Shuenn-Chen Yang, Mei-Ling Tsai, et al.. (2019). 4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulin. European Journal of Medicinal Chemistry. 181. 111584–111584. 12 indexed citations

Lin, Ching-Wen, Shu‐Ping Wang, Yih‐Leong Chang, et al.. (2016). Daxx inhibits hypoxia-induced lung cancer cell metastasis by suppressing the HIF-1α/HDAC1/Slug axis. Nature Communications. 7(1). 13867–13867. 76 indexed citations

Huang, Kuo‐Yen, Shih-Han Kao, Chi‐Yuan Chen, et al.. (2015). Small Molecule T315 Promotes Casitas B-Lineage Lymphoma–Dependent Degradation of Epidermal Growth Factor Receptor via Y1045 Autophosphorylation. American Journal of Respiratory and Critical Care Medicine. 193(7). 753–766. 18 indexed citations

Chen, Chi‐Yuan, Shuenn-Chen Yang, Kuo‐Hsiung Lee, et al.. (2014). The Antitumor Agent PBT-1 Directly Targets HSP90 and hnRNP A2/B1 and Inhibits Lung Adenocarcinoma Growth and Metastasis. Journal of Medicinal Chemistry. 57(3). 677–685. 23 indexed citations

Lin, Ching-Wen, S.‐Ja Tseng, Ivan M. Kempson, et al.. (2013). Extracellular delivery of modified oligonucleotide and superparamagnetic iron oxide nanoparticles from a degradable hydrogel triggered by tumor acidosis. Biomaterials. 34(17). 4387–4393. 37 indexed citations

Yeh, Chi‐Tai, Alexander T.H. Wu, Peter Mu‐Hsin Chang, et al.. (2012). Trifluoperazine, an Antipsychotic Agent, Inhibits Cancer Stem Cell Growth and Overcomes Drug Resistance of Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 186(11). 1180–1188. 170 indexed citations

Yang, Xiaoming, Qian Shi, Chin-Yu Lai, et al.. (2012). Antitumor Agents 295. E-Ring Hydroxylated Antofine and Cryptopleurine Analogues as Antiproliferative Agents: Design, Synthesis, and Mechanistic Studies. Journal of Medicinal Chemistry. 55(15). 6751–6761. 22 indexed citations

10.

Yang, Xiaoming, Qian Shi, Shuenn-Chen Yang, et al.. (2011). Antitumor Agents 288: Design, Synthesis, SAR, and Biological Studies of Novel Heteroatom-Incorporated Antofine and Cryptopleurine Analogues as Potent and Selective Antitumor Agents. Journal of Medicinal Chemistry. 54(14). 5097–5107. 34 indexed citations

11.

Nakagawa‐Goto, Kyoko, Pei-Chi Wu, Kenneth F. Bastow, et al.. (2011). Antitumor agents 283. Further elaboration of Desmosdumotin C analogs as potent antitumor agents: Activation of spindle assembly checkpoint as possible mode of action. Bioorganic & Medicinal Chemistry. 19(5). 1816–1822. 11 indexed citations

12.

Yang, Xiaoming, Qian Shi, Yi-Nan Liu, et al.. (2009). Antitumor Agents 268. Design, Synthesis, and Mechanistic Studies of New 9-Substituted Phenanthrene-Based Tylophorine Analogues as Potent Cytotoxic Agents. Journal of Medicinal Chemistry. 52(16). 5262–5268. 42 indexed citations

13.

Pan, Szu‐Hua, Hsuan‐Yu Chen, Pei-Fang Hung, et al.. (2009). Long form collapsin response mediator protein-1 (LCRMP-1) expression is associated with clinical outcome and lymph node metastasis in non-small cell lung cancer patients. Lung Cancer. 67(1). 93–100. 27 indexed citations

14.

Chen, Tzu-Chi, Sheng‐An Lee, Tse‐Ming Hong, et al.. (2009). From Midbody Protein−Protein Interaction Network Construction to Novel Regulators in Cytokinesis. Journal of Proteome Research. 8(11). 4943–4953. 22 indexed citations

15.

Wu, Cheng-Chung, Shuenn-Chen Yang, Jeremy J.W. Chen, et al.. (2008). Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPα. Molecular Cancer Therapeutics. 7(6). 1365–1375. 17 indexed citations

16.

Pan, Szu‐Hua, Shuenn-Chen Yang, Sung‐Liang Yu, et al.. (2008). Claudin-1 Is a Metastasis Suppressor and Correlates with Clinical Outcome in Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 179(2). 123–133. 146 indexed citations

17.

Hong, Tse‐Ming, Yuh-Ling Chen, Yi-Ying Wu, et al.. (2007). Targeting Neuropilin 1 as an Antitumor Strategy in Lung Cancer. Clinical Cancer Research. 13(16). 4759–4768. 163 indexed citations

18.

Shih, Jin‐Yuan, Yuan-Chii G. Lee, Shuenn-Chen Yang, et al.. (2003). Collapsin response mediator protein-1: A novel invasion-suppressor gene. Clinical & Experimental Metastasis. 20(1). 69–76. 45 indexed citations

19.

Shih, Jin‐Yuan, Shuenn-Chen Yang, Chong‐Jen Yu, et al.. (1997). Elevated Serum Levels of Mucin-associated Antigen in Patients with Acute Respiratory Distress Syndrome. American Journal of Respiratory and Critical Care Medicine. 156(5). 1453–1457. 13 indexed citations

20.

Chu, Yi-Wen, Pan‐Chyr Yang, Shuenn-Chen Yang, et al.. (1997). Selection of Invasive and Metastatic Subpopulations from a Human Lung Adenocarcinoma Cell Line. American Journal of Respiratory Cell and Molecular Biology. 17(3). 353–360. 384 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact